Cellebrite DI Ltd.CLBTNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank30
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P30
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.24% |
| Q3 2025 | 11.47% |
| Q2 2025 | 4.07% |
| Q1 2025 | 0.83% |
| Q4 2024 | 8.81% |
| Q3 2024 | 6.40% |
| Q2 2024 | -1.37% |
| Q1 2024 | 6.11% |
| Q4 2023 | 10.64% |
| Q3 2023 | -1.60% |
| Q2 2023 | 1.11% |
| Q1 2023 | 15.65% |
| Q4 2022 | -11.24% |
| Q3 2022 | 3.37% |
| Q2 2022 | 4.82% |
| Q1 2022 | 13.32% |
| Q4 2021 | -26.59% |
| Q3 2021 | 59.26% |
| Q2 2021 | -1.21% |
| Q1 2021 | 5.17% |
| Q4 2020 | 12.25% |
| Q3 2020 | -1.47% |
| Q2 2020 | -1.79% |
| Q1 2020 | 0.00% |